# Associations of plasma p‐tau231 with serial position recall performance in free‐of‐dementia individuals

**Authors:** Davide Bruno, Chelsea Reichert‐Plaska, Ainara Jauregi‐Zinkunegi, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Nunzio Pomara

PMC · DOI: 10.1111/jnp.70012 · 2025-09-23

## TL;DR

This study shows that plasma p-tau231 levels are linked to memory performance in older adults without dementia, suggesting early signs of Alzheimer's disease.

## Contribution

The study introduces serial position recall, especially delayed primacy, as a novel tool for detecting AD pathology in cognitively unimpaired individuals.

## Key findings

- Plasma p-tau231 levels were associated with delayed primacy recall performance.
- Higher delayed primacy recall was linked to lower p-tau231 levels.
- Serial position analysis improves early detection of AD-related pathology.

## Abstract

Cognitive assessment and analysis of plasma biomarkers are lower‐cost options for the early assessment of Alzheimer's disease (AD). In this study, we examined whether serial position markers in the Rey's AVLT were sensitive to plasma AD biomarkers in cognitively unimpaired older individuals. Participants (n = 327; mean age = 70.4, SD = 10.4) were free of dementia (MMSE = 24+) at baseline and recruited as part of the Memory Evaluation Research Initiative (MERI; Nathan Kline Institute, NY, USA). Data included plasma p‐tau231, Aβ40 and Aβ42, AVLT scores and demographics. Bayesian linear and logistic regression analyses were carried out with plasma biomarkers as outcomes (including the Aβ42/40 ratio); memory scores, including traditional metrics and serial position scores, were predictors; and age, years of education, APOE ε4‐status and reported gender were control variables. Results indicated that plasma p‐tau231 was associated primarily with delayed primacy recall (first four words): the more primacy words were recalled, the lower the plasma p‐tau231 levels were. This study confirms that serial position analysis of word‐list recall data, and particularly delayed primacy, is a valuable tool for the identification of in vivo AD‐related pathology in cognitively unimpaired individuals.

## Linked entities

- **Diseases:** Alzheimer's disease (MONDO:0004975), dementia (MONDO:0001627)

## Full-text entities

- **Genes:** APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}
- **Diseases:** dementia (MESH:D003704), AD (MESH:D000544)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12976847/full.md

---
Source: https://tomesphere.com/paper/PMC12976847